We are live on ! Find out more
FA

FCG Advisors Portfolio holdings

AUM $425M
1-Year Est. Return 12.09%
This Fund
S&P 500
This Quarter Est. Return
+8.41%
1 Year Est. Return
+12.09%
3 Year Est. Return
+19.73%
5 Year Est. Return
+52.93%
10 Year Est. Return
–
AUM
$349M
AUM Growth
+$20.8M
Cap. Flow
-$3.06M
Cap. Flow %
-0.88%
Top 10 Hldgs %
55.23%
Holding
173
New
13
Increased
88
Reduced
49
Closed
8

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$13.7M
2
IVW icon
iShares S&P 500 Growth ETF
IVW
+$3.06M
3
VXF icon
Vanguard Extended Market ETF
VXF
+$1.73M
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$865K
5
BX icon
Blackstone
BX
+$811K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$17.8M
2
BSCJ
Invesco BulletShares 2019 Corporate Bond ETF
BSCJ
+$5.07M
3
BSJJ
Invesco BulletShares 2019 High Yield Corporate Bond ETF
BSJJ
+$3.23M
4
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$2.37M
5
ADBE icon
Adobe
ADBE
+$608K

Sector Composition

Rank Sector Weight
1 Healthcare 7.13%
2 Financials 4.5%
3 Technology 3.87%
4 Communication Services 1.86%
5 Energy 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CB icon
151
Chubb
CB
$137B
$221K 0.06%
1,423
-69
-5% -$10.6K
RING icon
152
iShares MSCI Global Gold Miners ETF
RING
$2.15B
$216K 0.06%
+8,988
New +$200K
V icon
153
Visa
V
$682B
$216K 0.06%
+1,150
New +$207K
TTEK icon
154
Tetra Tech
TTEK
$8.2B
$215K 0.06%
12,500
– –
FITB
155
Fifth Third Bancorp
FITB
$52.6B
$211K 0.06%
+6,879
New +$202K
GD icon
156
General Dynamics
GD
$99.7B
$211K 0.06%
1,199
– –
IGSB icon
157
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$210K 0.06%
+3,915
New +$210K
UNP icon
158
Union Pacific
UNP
$179B
$205K 0.06%
+1,134
New +$194K
KMB icon
159
Kimberly-Clark
KMB
$36B
$202K 0.06%
1,467
+1
+0.1% +$135
ARCC icon
160
Ares Capital
ARCC
$13.8B
$198K 0.06%
10,591
+216
+2% +$4.01K
TGTX icon
161
TG Therapeutics
TGTX
$8.4B
$170K 0.05%
+15,300
New +$116K
DPLO
162
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$136K 0.04%
34,000
– –
F icon
163
Ford
F
$56.7B
$112K 0.03%
12,007
+69
+0.6% +$620
LYG icon
164
Lloyds Banking Group
LYG
$86.6B
$67K 0.02%
20,277
+1,695
+9% +$5.13K
ATNM icon
165
Actinium Pharmaceuticals
ATNM
$28.9M
$8K ﹤0.01%
+1,257
New +$8.67K
ADBE icon
166
Adobe
ADBE
$94.3B
– –
-2,200
Closed -$608K
AMLP icon
167
Alerian MLP ETF
AMLP
$12.7B
– –
-3,372
Closed -$154K
COST icon
168
Costco
COST
$417B
– –
-699
Closed -$201K
MKL icon
169
Markel Group
MKL
$24.7B
– –
-205
Closed -$242K
BSJJ
170
DELISTED
Invesco BulletShares 2019 High Yield Corporate Bond ETF
BSJJ
– –
-135,168
Closed -$3.23M
BSCJ
171
DELISTED
Invesco BulletShares 2019 Corporate Bond ETF
BSCJ
– –
-240,457
Closed -$5.07M
CELGZ
172
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
– –
-52,807
Closed -$30K
CELG
173
DELISTED
Celgene Corp
CELG
– –
-179,710
Closed -$17.8M
3 4 5 6
7

Similar funds

LWS
Lucia Wealth Services San Diego, California $426M AUM 19.43% 1-Year Est. Return
VCP
Vestar Capital Partners New York $435M AUM 20.18% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
AIM
AIA Investment Management Singapore $437M AUM 45.1% 1-Year Est. Return
MGAI
MP Global Advisers III New York $406M AUM 20.67% 1-Year Est. Return
CPF
Context Partners Fund La Jolla, California $460M AUM
IA
Independence Advisors Wayne, Pennsylvania $466M AUM 11.32% 1-Year Est. Return
F
Filament Seattle, Washington $369M AUM 35.25% 1-Year Est. Return

FCG Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, FCG Advisors held 173 positions worth $349M, up 6.3% from $328M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

FCG Advisors's Q4 2019 filing shows 13 new, 88 increased, 49 reduced and 8 closed positions. Its largest new stake was KKR & Co: 27,845 shares worth $812K. The largest sale was Celgene Corp, an estimated $17.8M.

By sector, the portfolio is most concentrated in Healthcare at 7.1% of assets, down from 8% a quarter earlier, followed by Financials and Technology.

  • FCG Advisors's largest Q4 2019 buy was KKR & Co: 27,845 shares worth $812K.
  • FCG Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $13.7M increase.
  • FCG Advisors's biggest Q4 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $2.37M.
  • FCG Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $17.8M.
  • FCG Advisors's ten largest holdings make up 55% of its $349M portfolio in Q4 2019.
  • FCG Advisors opened 13 new positions and closed 8 in Q4 2019.
  • FCG Advisors's portfolio value rose 6.3% quarter-over-quarter to $349M.

Based on FCG Advisors's 13F filing for Q4 2019, filed 29 Jan 2020.